Puliga, Elisabetta http://orcid.org/0000-0002-1049-9728
De Bellis, Chiara
Vietti Michelina, Sandra
Capeloa, Tania
Migliore, Cristina
OrrĂ¹, Claudia
Baiocchi, Gian Luca
De Manzoni, Giovanni
Pietrantonio, Filippo
Reddavid, Rossella
Fumagalli Romario, Uberto
Ambrogio, Chiara
Corso, Simona
Giordano, Silvia
Funding for this research was provided by:
Fondazione AIRC per la ricerca sul cancro ETS (IG 27531)
Article History
Received: 4 August 2023
Accepted: 5 January 2024
First Online: 23 January 2024
Declarations
:
: Filippo Pietrantonio reported receiving research grants from BMS, Incyte, Agenus, Amgen, Lilly and AstraZeneca, and personal fees from BMS, MSD, Amgen, Merck-Serono, Pierre-Fabre, Servier, Bayer, Takeda, Astellas, Johnson&Johnson, Rottapharm, Ipsen, AstraZeneca, GSK, Daiichi-Sankyo outside the submitted work. All the other authors declare that they have no conflict of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
: Informed consent to be included in the study, or the equivalent, was obtained from all patients.
: All institutional and national guidelines for the care and use of laboratory animals were followed.